The Incidence of Neonatal Hypoglycemia while Reducing Glucose Infusion Rate of Newborns with no Previous History of Hypoglycemia in Vajira Hospital
Article Sidebar
Main Article Content
Abstract
Objective: To study the incidence of hypoglycemia post-GIR (glucose infusion rate) reduction in newborns with no prior history of hypoglycemia in the Neonatal Semi-intensive Care Unit (NSCU) at the Faculty of Medicine Vajira Hospital Navamindradhiraj University
Method: A descriptive prospective study was conducted in hypoglycemia-free newborns admitted into the NSCU. Data were collected from newborns who had never had hypoglycemia but sustained certain conditions that necessitated intravenous glucose infusions. The newborns’ blood glucose levels were then monitored using a glucometer after GIR reduction. The study was conducted on newborns in the Neonatal semi-intensive care unit (NSCU) at the Faculty of Medicine, Vajira Hospital, from August 2016 to August 2017. The main outcome measured was the incidence of hypoglycemia in the NSCU ward
Result: Only one newborn out of the total 201 studied suffered hypoglycemia post GIR reduction. The incidence rate was thus 1/201 (0.5%). There was also only one incidence out of the total 360 blood tests, or equivalent to 1/360 (0.3%). This occurred in an infant with low birth weight (LBA with AGA), together with neonatal sepsis and feeding intolerance.
Conclusion: Only one newborn was found to have hypoglycemia after decreasing the GIR. This neonate had actually endured feeding intolerance and sepsis. Therefore, to lessen ordinary patients’ pain, reduce the workload of phlebotomists, and cut down the cost of blood testing, we may consider canceling the blood glucose level monitoring after GIR reduction in this patient group. However, the size of the study group was not large enough for statistical significance, so we should continue to closely observe the symptoms of hypoglycemia in this group.
Article Details
References
2. Stanley C, Rozance P, Thornton P, De Leon D, Harris D, Haymond M, et.al. Re-evaluating “Transitional neonatal hypoglycemia”: mechanism and implications for management. J Pediatr. 2015; 166: 1520-5.
3. Cloherty J, Eichenwald E, Hansen A, Stark A. Manual of Neonatal Care. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2012: 284-90.
4. David AH. and committee on fetus and newborn. Clinical report postnatal glucose homeostasis in late-preterm and term infant. Pediatrics. 2011; 127: 575-9.
5. สถิติข้อมูลหอผู้ป่วยทารกแรกเกิดกึ่งวิกฤติ ประจำปี พ.ศ. 2557 ถึง พ.ศ. 2558 รายงานประจ?ำปีของคณะ แพทยศาสตร์วชิรพยาบาล หาวิทยาลัยนวมินทราธิราช.
6. ประชา นันท์นฤมิต. การประยุกต์ความรู้ทางสรีรวิทยา ในการดูแลทารกแรกเกิด. พิมพ์ครั้งที่ 1. กรุงเทพฯ: โฮลิสติก พับลิชชิ่ง, 2558: 135-53.
7. TERUMO MEDISAFE FIT Item specification. Terumo. (updated 2016 May 6; cited 2018 May 1). Available from: https://www.terumo-europe. com/en-emea/diabetes-management/bloodglucose-meters/medisafe-fit%C2%AE.
8. Chih Y, Cheng T, Cheng S, Ting E., Ming H, Chau J. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther. 2011; 13: 1-5.
9. Ames C. Rapid detection of neonatal hypoglycemia evaluation of dextrostix reflectance meter system. BMJ journal. 1973; 48: 398-400.
10. Nayeri F, Mamak S, Behbahani H, Dehghan P, Ebrahim B. Blood glucose measurement by glucometer in comparison with standard method in diagnosis of neonatal hypoglycemia. Acta Medica Iranica, 2014; 52, 620-2.
11. Harris D, Weston P, Harding J. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012; 161: 787-91.
12. อารีรัตน์ ชัยเรืองยศ. ความชุกและปัจจัยที่เกี่ยวข้องกับภาวะน้ำตาลในเลือดต่ำในทารกแรกเกิดก่อนกำหนดก่อนจำหน่ายกลับบ้าน. วชิรเวชสาร 2556; 57: 89-94.
13. Gomerlla T, Cunningham M, Eyal F. LANGE Neonatalogy Management, procedure, on-call problem, diseases, and drugs. 7th ed. United States: McGraw-Hill Education, 2013: p.427-36.
14. แนวทางปฏิบัติของทารกแรกเกิด คณะแพทยศาสตร์วชิรพยาบาล มหาวิทยาลัยนวมินทราธิราช ลงวันที่ 3 ตุลาคม พ.ศ. 2553.